Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition
CA 2488366 C · Owner: Duotol Ab · Inventors: Holmgren, Jan; Harandi, Ali M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A bifunctional composition comprising an intracellularly effective immunomodulating nucleic acid component containing at least one immunostimulatory, immunoinhibitory or immunomodulating motif and selected from a mononucleotide, a dinucleotide, an oligonucleotide or a polynucleotide with either a natural phosphodiester backbone or a modified backbone optionally in combination with a specific antigen in association with a , protein binding to specific receptors on mammalian cell surfaces selected from the group consisting of cholera toxin (CT) the subunit B of CT (CTB), Escherichia coli heat labile enterotoxin (LT) the subunit B of LT (LTB), and , proteins or protein derivatives that …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 2003 and granted July 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 5, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.